Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,500
Closed -$4.08K 528
2024
Q3
$4.08K Hold
1,500
﹤0.01% 412
2024
Q2
$3.63K Hold
1,500
﹤0.01% 440
2024
Q1
$3.94K Hold
1,500
﹤0.01% 387
2023
Q4
$2.81K Hold
1,500
﹤0.01% 418
2023
Q3
$2.97K Hold
1,500
﹤0.01% 411
2023
Q2
$3.03K Hold
1,500
﹤0.01% 419
2023
Q1
$2.81K Hold
1,500
﹤0.01% 436
2022
Q4
$3.12K Hold
1,500
﹤0.01% 411
2022
Q3
$3.1K Hold
1,500
﹤0.01% 454
2022
Q2
$3.21K Hold
1,500
﹤0.01% 448
2022
Q1
$5.04K Sell
1,500
-1,500
-50% -$4.84K ﹤0.01% 433
2021
Q4
$7.5K Buy
+3,000
New +$10.1K 0.01% 433

Other funds holding IMRN

Stephens Consulting's IMRN Position: Q4 2024 in Review

Stephens Consulting sold out of Immuron (IMRN) in Q4 2024, closing a stake of 1,500 shares — an estimated $4.08K sold.

Stephens Consulting first reported a position in IMRN in Q4 2021 and held it in 12 quarters. The position peaked at $7.5K in Q4 2021. 1 fund tracked by Wall St. Rank holds IMRN as of Q4 2024.

  • Stephens Consulting reported no remaining Immuron position as of Q4 2024 after selling out during the quarter.
  • Stephens Consulting sold 1,500 Immuron shares in Q4 2024, an estimated $4.08K.
  • Stephens Consulting first reported a position in Immuron in Q4 2021 and held it in 12 quarters.
  • Stephens Consulting's Immuron position peaked at $7.5K in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Immuron as of Q4 2024.

Based on Stephens Consulting's 13F filing for Q4 2024, filed 27 Jan 2025.